Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · April 24, 2024

Whole-Body vs Targeted Narrowband UVB Phototherapy for the Treatment of Patients With Acral Vitiligo

Photodermatology, Photoimmunology & Photomedicine


Additional Info

Photodermatology, Photoimmunology & Photomedicine
Whole-body and targeted narrowband ultraviolet B phototherapy effectively stabilize acral vitiligo with negligible repigmentation beyond wrists and ankles: Results from a split-body randomized controlled trial
Photodermatol Photoimmunol Photomed 2024 Mar 01;40(2)e12960, A Thind, K Vinay, H Mehta, A Bishnoi, MS Kumaran, D Parsad

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading